This Medudy course is a video tutorial for physicians on the topic of "Topical roflumilast foam for psoriasis capitis". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you.
Plaque psoriasis is a chronic inflammatory skin disease that frequently affects the scalp and is often accompanied by itching, which significantly impairs quality of life. Topical treatment of the scalp is difficult due to the interfering hair. Roflumilast, which is available as a foam formulation, modulates inflammatory processes, relieves itching and presumably supports the skin barrier function. Today's study therefore investigated the efficacy and safety of Roflumilast foam in patients with psoriasis of the scalp and body.
Note: All "speakers" appearing in the Medudy videos are AI-based avatars used to improve the didactics of the videos. The people on whom the avatars are based have explicitly consented to their use. All content is based on high-quality scientific sources and is created and reviewed by the Medudy medical team.
This "Journal Club Summary" in video format shows how roflumilast foam (0.3%) can be used as a topical monotherapy for psoriasis with body and scalp lesions - concisely summarized.
Plaque psoriasis is a chronic inflammatory skin disease that often affects the scalp. However, topical therapies are often difficult to use in hairy areas. Therefore, today's study investigated whether Roflumilast can be used effectively and safely as a foam formulation for the treatment of plaque psoriasis of the scalp and body.
At the end of this training you will know:
- the clinical background and relevance of the research question under investigation
- Study design and methodology of the publication to answer the research question
- the results and key takeaways of the publication
- the conclusion of the publication and possible limitations
